HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: R600006-MCP200v1 5/10/1811    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nedelkov, D. Articles by Nelson, R. W. Search for Related Content PubMed PubMed Citation Articles by Nedelkov, D. Articles by Nelson, R. W. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 5:1811-1818, 2006.
© 2006 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Cancer

Population Proteomics

The Concept, Attributes, and Potential for Cancer Biomarker Research^*

Dobrin Nedelkov^,,¶, Urban A. Kiernan, Eric E. Niederkofler, Kemmons A. Tubbs and Randall W. Nelson

From the Intrinsic Bioprobes, Inc. and Institute for Population Proteomics, Tempe, Arizona 85281

This review outlines the concept of population proteomics and its implication in the discovery and validation of cancer-specific protein modulations. Population proteomics is an applied subdiscipline of proteomics engaging in the investigation of human proteins across and within populations to define and better understand protein diversity. Population proteomics focuses on interrogation of specific proteins from large number of individuals, utilizing top-down, targeted affinity mass spectrometry approaches to probe protein modifications. Deglycosylation, sequence truncations, side-chain residue modifications, and other modifications have been reported for myriad of proteins, yet little is know about their incidence rate in the general population. Such information can be gathered via population proteomics and would greatly aid the biomarker discovery efforts. Discovery of novel protein modifications is also expected from such large scale population proteomics, expanding the protein knowledge database. In regard to cancer protein biomarkers, their validation via population proteomics-based approaches is advantageous as mass spectrometry detection is used both in the discovery and validation process, which is essential for the detection of those structurally modified protein biomarkers.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y. Ma, J. Peng, W. Liu, P. Zhang, L. Huang, B. Gao, T. Shen, Y. Zhou, H. Chen, Z. Chu, et al. Proteomics Identification of Desmin as a Potential Oncofetal Diagnostic and Prognostic Biomarker in Colorectal Cancer Mol. Cell. Proteomics, August 1, 2009; 8(8): 1878 - 1890. [Abstract] [Full Text] [PDF]

				A. Dincer, S. Onal, S. Timur, A. Zeytunluoglu, E. Duman, and F. Zihnioglu Differentially displayed proteins as a tool for the development of type 2 diabetes Ann Clin Biochem, July 1, 2009; 46(4): 306 - 310. [Abstract] [Full Text] [PDF]

				R. L. Gundry and J. E. Van Eyk Unraveling the Complexity of Circulating Forms of Brain Natriuretic Peptide Clin. Chem., July 1, 2007; 53(7): 1181 - 1182. [Full Text] [PDF]

				D. Nedelkov, D. A. Phillips, K. A. Tubbs, and R. W. Nelson Investigation of Human Protein Variants and Their Frequency in the General Population Mol. Cell. Proteomics, July 1, 2007; 6(7): 1183 - 1187. [Abstract] [Full Text] [PDF]